Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.66USD
23 Apr 2019
Change (% chg)

$0.03 (+0.83%)
Prev Close
$3.63
Open
$3.58
Day's High
$3.68
Day's Low
$3.57
Volume
45,887
Avg. Vol
46,680
52-wk High
$6.88
52-wk Low
$2.33

Schapfel, Dieter 

Dr. Dieter Schapfel, M.D., is Chief Medical Director, Enzo Clinical Labs of the company. Dr. Schapfel served as Medical Director of Pathology at Southside Hospital–North Shore/Long Island Jewish Health System from 2006 to 2012. Dr. Schapfel served as a staff pathologist at Huntington Hospital from January 2004 to June 2006. Dr. Schapfel served as Director of Pathology and Medical Affairs and the College of American Pathologists Director of Pathology, Dublin, Ireland and Farmingdale, NY for Icon Laboratories from February 2002 to October 2003. Dr. Schapfel is a graduate of the State University of New York at Stony Brook, College of Medicine, where he also served his residency. He is a diplomat of the American Board of Pathology with certification in Anatomic and Clinical Pathology and is also a diplomat of The National Board of Medical Examiners.

Basic Compensation

Total Annual Compensation, USD 323,077
Restricted Stock Award, USD 17,680
Long-Term Incentive Plans, USD --
All Other, USD 129,319
Fiscal Year Total, USD 470,076

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018